STOCKHOLM -- MGI Tech Co. Ltd. ("MGI"), a company committed to building core tools and technology to lead life science, are delighted to announce a comprehensive collaboration with AddLife AB, one of Europe's largest distributors of clinical testing and laboratory equipment, headquartered in Stockholm. This partnership aims to significantly enhance the distribution of MGI products* in the Nordic region, [...]

FOSTER CITY, Calif. -- Acrobat Genomics, NanoString Technologies, Inc. (NASDAQ:NSTG), and the Illumina Accelerator announced today their collaboration with Stanford Medicine to discover new drug targets for gene editing-based therapeutics using GeoMx® Digital Spatial Profiling (DSP) technology. This collaboration aims to improve treatment options for patients suffering from interstitial lung diseases, such as idiopathic pulmonary [...]

BOSTON -- The Institute for Protein Innovation (IPI), a nonprofit research institute, and Addgene, a global nonprofit biorepository, today announced a strategic partnership to accelerate biomedical research and therapeutic development through the discovery, development, and distribution of recombinant antibodies and other protein and DNA reagents. This partnership will help address the ongoing need by the global [...]

LAUSANNE, Switzerland and DANVERS, MA, USA – Lunaphore, a Swiss life sciences company developing technology to enable spatial biology in every laboratory, and Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, today announced a partnership to enable the use of CST® antibodies on the Lunaphore COMET™ platform, a scalable [...]

DKSH has signed a new partnership with Quantabio, a leading provider of DNA and RNA reagents for molecular testing applications in life science research, in Thailand. Bangkok, Thailand - DKSH Business Unit Technology has signed an agreement with Quantabio, LLC. DKSH will provide full Market Expansion Services, including market insights, marketing and sales, distribution and [...]

UTRECHT, the Netherlands -- Single Cell Discoveries, a Contract Research Organization (CRO) dedicated to single-cell sequencing, is proud to announce the first delivery of the new Illumina NovaSeq X Plus sequencing system in the Benelux. This milestone achievement solidifies Single Cell Discoveries' commitment to driving innovation and delivering high-impact insights to biopharmaceutical companies, health systems, and academic [...]

BetaLife wins top prize with its potential to provide regenerative medicines to patients with severe diabetes in Southeast Asia. Cytiva’s BioChallenge aims to support the innovation of biotech startups. Cytiva recognizes the talent, resource and scalability constraints faced by small to medium-sized biotechs in Southeast Asia. As such, it brought its global competition, BioChallenge, for [...]

TAIPEI, Taiwan and VACAVILLE, Calif. — Polaris Group (TWSE: 6550), a multinational biopharmaceutical company focused on research and development of novel biological drugs for cancer and other metabolic diseases, today announced that Polaris Group’s strategic partner, Nanotein Technologies, has just launched GROW-NK, a novel Natural Killer (NK) cell activation and expansion reagent. This reagent is [...]

World-class laboratory and office space underpins the scaling of Quantum-Si’s operational and development capabilities in support of its goal to revolutionize protein sequencing. Company continues rich 10 year history in Connecticut with new facility through 2029 BRANFORD, Conn. -- Quantum-Si- Incorporated (Nasdaq: QSI) (“Quantum-Si,” “QSI” or the “Company”), The Protein Sequencing Company™, today announced the official debut of [...]

Together, an extensive panel of consented patient samples and iPSC technology will advance AD drug development and patient stratification. CAMBRIDGE / EDINBURGH and ALDERLEY PARK, UK: Axol Bioscience Ltd. (Axol), a leading pluripotent stem cell technology provider for drug discovery has signed an exclusive agreement with StrataStem to access and commercialize its extensive collection of Alzheimer’s [...]